Skip to main content

Find Clinical Trials

Home
Conditions
Motor Neuron Disease

Clinical trial condition

Motor Neuron Disease

Explore clinical trials studying Motor Neuron Disease. Study availability and eligibility vary by location and protocol.

839 public trials 197 recruiting studies

Refine in advanced search Browse all conditions

Motor Neuron Disease trial results

Not Yet Recruiting

Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

NCT05423678

Conditions: ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluation of the Early Use of the Pressure Relaxer in the Respiratory Impairment of Patients With Amyotrophic Lateral Sclerosis: Multicenter Randomized Controlled Study.

NCT05297487

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Investigation of Cannabinoid 2-receptor Expression in the Brain and Spine of ALS-patients Compared to Healthy Controls With PET (18F-RoSMALS)

NCT05880563

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Muskelzentrum/ALS-Clinic, Kantonsspital St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)

NCT07047209

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Nova Southeastern University Davie, Florida, United States

Northwestern Universsity Chicago, Illinois, United States

MGH Boston, Massachusetts, United States

View Trial Details

Completed

Equine-Assisted Physiotherapy for Spinal Muscular Atrophy

NCT05341453

Conditions: Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
Locations: Kamila Řasová Prague, Czechia

View Trial Details

Completed

Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP

NCT05562960

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT00330681

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III

NCT00415519

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis

NCT01492686

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Osaka, Japan

View Trial Details

Completed

Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00424463

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: National Hospital Organization Miyagi National Hospital Watari-gun, Miyagi, Japan

View Trial Details